Centene(US:CNC) GlobeNewswire News Roomยท2025-07-30 22:20Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Centene Corporation due to misleading statements regarding the company's enrollment and morbidity rates, which led to significant financial losses for investors [3][5]. Group 1: Legal Actions and Investor Information - Investors who suffered losses exceeding $75,000 in Centene between December 12, 2024, and June 30, 2025, are encouraged to contact Faruqi & Faruqi for legal options [1]. - There is a deadline of September 8, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against Centene [3]. - The lead plaintiff is defined as the investor with the largest financial interest who directs the litigation on behalf of the class [7]. Group 2: Company Performance and Stock Impact - Centene's stock price fell dramatically from $56.65 per share on July 1, 2025, to $33.78 per share on July 2, 2025, marking a decline of 40.4% following the withdrawal of 2025 guidance [6]. - The company revised its guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75 after a preliminary analysis indicated lower-than-expected market growth across 22 states, which represents 72% of its marketplace membership [5]. Group 3: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4].